David Steinberg

General Partner at Longwood Fund Management LLC

David Steinberg

David Steinberg

General Partner at Longwood Fund Management LLC

Overview
Career Highlights

Knode, Inc.
Pyxis Oncology
ENDRA Life Sciences, Inc.

RelSci Relationships

263

Number of Boards

12

Birthday

1973

Age

47

Contact Data
Trying to get in touch with David Steinberg? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals David Steinberg likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at PureTech Health PLC

Relationship likelihood: Strong

Co-Founder at PureTech Health PLC

Relationship likelihood: Strong

Co-Founder at Vedanta Biosciences, Inc.

Relationship likelihood: Strong

Partner at SV Health Investors LLP

Relationship likelihood: Strong

Founder at Kew, Inc.

Relationship likelihood: Strong

Founder at Alnylam Pharmaceuticals, Inc.

Relationship likelihood: Strong

Director-Tumor Biology Steele Lab at The Massachusetts General Hospital

Relationship likelihood: Strong

Founder at Kew, Inc.

Relationship likelihood: Strong

Co-Founder at Pyxis Oncology

Relationship likelihood: Strong

Co-Founder at Karuna Therapeutics, Inc.

Relationship likelihood: Strong

Paths to David Steinberg
Potential Connections via
Relationship Science
You
David Steinberg
General Partner at Longwood Fund Management LLC
Education
BA in Biology, with Distinction

Cornell is a privately endowed research university and a partner of the State University of New York. As the federal land-grant institution in New York State, they have a responsibility—unique within the Ivy League—to make contributions in all fields of knowledge in a manner that prioritizes public engagement to help improve the quality of life in our state, the nation, the world.

MBA in Strategy & Finance, with High Honors

The University of Chicago Booth School of Business is a graduate business school located in Chicago, Illinois, at the University of Chicago. Formerly known as the University of Chicago Graduate School of Business, Chicago Booth is the second-oldest business school in the U.S., the first such school to offer an Executive MBA program, and the first to initiate a Ph.D. program in business. The school was renamed in 2008 following a $300 million endowment gift to the school by alumnus David G. Booth. The school has the third-largest endowment of any business school. The school's flagship campus is located in the Hyde Park neighborhood of Chicago on the main campus of the university. The school also maintains additional campuses in London and Asia (originally Singapore, but in July 2013 a move to Hong Kong was announced), as well as in downtown Chicago on the Magnificent Mile. In addition to conducting graduate business programs, the school conducts research in the fields of finance, economics, quantitative marketing research, and accounting. Chicago Booth is currently ranked first in the United States by Bloomberg Businessweek and first globally by the Economist.

UCE’s Office of Investments is responsible for managing the University's investment assets, which includes overseeing the endowment to ensure that it benefits both current and future generations of the University of Chicago. They oversee the broad investment strategy and provide input to the development of the strategic and tactical investment policies of the University & UCMC endowments, pension plans and self-insurance trust assets. Their strategy combines qualitative and quantitative analysis, seeking to achieve superior investment performance on a risk-adjusted basis.

Career History
General Partner
2018 - Current

Longwood Fund Management invests in companies located in the US. The firm targets companies operating in the fields healthcare and science companies. They provides financing for early stage capital requirements.

Chief Business Officer
2006 - Current

Follica, Inc. develops therapies for hair follicle disorders. The firm provides an out-patient therapy coupled with an at-home system for the treatment of androgenetic alopecia (hair loss) and medical device development fields to develop and commercialize its product platform. The company was founded by Rox R. Anderson, George Cotsarelis, Vera Price, Daphne Zohar, David Steinberg, and Bernat Olle in 2006 and is headquartered in Boston, MA.

President, Secretary, Treasurer & Director
Current

Knode, Inc. develops and delivers web-based life science solutions for accessing experts and their content. It offers solutions for project team formation, post-merger integration, collaborations, business development, and decision-making applications. The firm provides services to pharmaceutical companies, academic institutions and researchers. The company was founded in 2011 and is headquartered in Boston, MA.

Boards & Committees
Member, Advisory Board
Current

Bio & Health Tech Entrepreneurship Lab NYC is a prestigious 6-month training and mentorship program for aspiring entrepreneurs in New York City’s life sciences and healthcare technology community. The Lab provides extensive support to graduate students of science, post-docs, early-career researchers and engineers interested in forming new biotech and health tech ventures.

Board Member
Prior

Cellicon Biotechnologies, Inc. develops pharmaceutical products. It offers technologies for decoding the protein pathway for the cure of human diseases such as diabetes, arthritis, and cancer. The company was founded in 2002 by Timothy Gardner and is headquartered in Boston, MA

Transactions
Details Hidden

Pyxis Oncology raised money in a private placement transaction

Investments
Details Hidden

Pyxis Oncology, Inc. develops antibody therapeutics. The company was founded by David Steinberg, Shaan Gandhi, and John Flavin and is headquartered in Boston, MA.

Details Hidden

Vedanta Biosciences, Inc. develops microbial therapies that address the human immune system. It engages in the development of a new class of drugs that work by modulating the human microbiome, with an initial emphasis in autoimmune and inflammatory diseases. The company was founded by Ruslan Medzhitov, Alexander Rudensky, Brett Finlay, Kenya Honda, Dan Littman, Bernat Olle and David Steinberg in 2010 and is headquartered in Cambridge, MA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by David Steinberg. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of David Steinberg's profile does not indicate a business or promotional relationship of any kind between RelSci and David Steinberg.